about
Self-Reported Facial Pain in UK Biobank Study: Prevalence and Associated FactorsCan large surveys conducted on highly selected populations provide valid information on the epidemiology of common health conditions? An analysis of UK Biobank data on musculoskeletal pain.Patient-reported improvements in health are maintained 2 years after completing a short course of cognitive behaviour therapy, exercise or both treatments for chronic widespread pain: long-term results from the MUSICIAN randomised controlled trial.The epidemiology of regional and widespread musculoskeletal pain in rural versus urban settings in those ≥55 yearsThe Maintaining Musculoskeletal Health (MAmMOTH) Study: Protocol for a randomised trial of cognitive behavioural therapy versus usual care for the prevention of chronic widespread pain.Alcohol Consumption in Relation to Risk and Severity of Chronic Widespread Pain: Results From a UK Population-Based Study.Maternal and perinatal risk factors for childhood cancer: record linkage study.Investigating generalizability of results from a randomized controlled trial of the management of chronic widespread pain: the MUSICIAN studyCognitive behavior therapy, exercise, or both for treating chronic widespread pain.The impact of moving from a widespread to multi-site pain definition on other fibromyalgia symptoms.The prevalence and management of low back pain across adulthood: results from a population-based cross-sectional study (the MUSICIAN study).ReplyModest Association of Joint Hypermobility With Disabling and Limiting Musculoskeletal Pain: Results From a Large-Scale General Population-Based SurveyWhat is the effect of alcohol consumption on the risk of chronic widespread pain? A Mendelian randomisation study using UK BiobankTreatment expectations but not preference affect outcome in a trial of CBT and exercise for painThe Prevalence of Fibromyalgia in the General Population: A Comparison of the American College of Rheumatology 1990, 2010, and Modified 2010 Classification CriteriaDevelopment of a clinical risk score for pain and function following total knee arthroplasty: results from the TRIO study
P50
Q34450990-E25FC02A-B487-4613-BE1F-506E01DC82CCQ35829708-04858188-82AB-40B8-B536-AD1CA20667D4Q36183834-6F6E3105-BB41-4DE3-8BD3-F8FB0960593EQ36196219-76F63012-11E2-431A-A7E4-99A30253E6E8Q36836637-21E0FFEC-4EBC-4C9A-88E6-CA1130920C53Q36866336-6E0F8372-D8CF-4AF5-9884-EC8276CEF93BQ37516222-A5571079-FF98-4F64-924F-D3E667B397D0Q37524045-E17DEB84-2540-4B32-A3FB-D1971A664C60Q38481226-E6BB2BB7-8B2E-47E1-AF9D-DC30CFE0D0ADQ38969463-CB50ECE3-E05E-4B26-B83F-D999CF580805Q45894636-ADD85739-F9C8-4529-955A-F3DDE3EC6838Q57751061-8496F681-9AA4-4545-90EC-2C4F7FF4E08DQ57751103-B086096B-2F61-41DA-A20B-2E29AE361283Q58115875-67B16984-5B09-4367-A4B7-166E0686DD18Q59820633-6D86E2E8-F5A8-43C9-8666-EA4AFE04D85CQ59820796-EF9AD238-BC2C-4399-A13A-B68F8E7A372EQ60730494-952FD563-2A72-4651-8A07-54294477B1E3
P50
description
researcher, ORCID id # 0000-0001-6045-386X
@en
wetenschapper
@nl
name
Marcus Beasley
@ast
Marcus Beasley
@en
Marcus Beasley
@es
Marcus Beasley
@nl
type
label
Marcus Beasley
@ast
Marcus Beasley
@en
Marcus Beasley
@es
Marcus Beasley
@nl
prefLabel
Marcus Beasley
@ast
Marcus Beasley
@en
Marcus Beasley
@es
Marcus Beasley
@nl
P106
P1153
54788841000
P31
P496
0000-0001-6045-386X